From professional translators, enterprises, web pages and freely available translation repositories.
caution is advised if ariclaim is co-administered with medicinal products that are predominantly metabolised by cyp2d6 (risperidone, tricyclic antidepressants [tcas] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
jāievēro piesardzība, kad ariclaim tiek lietots vienlaikus ar zāļu līdzekļiem, ko metabolizē galvenokārt cyp2d6 (risperidons, tricikliskie antidepresanti, piemēram, nortriptilīns, amitriptilīns un imipramīns, īpaši tad, ja tiem ir šaurs terapeitiskais indekss (piemēram, flekainīds, propafenons un metoprolols).